Sandostatin Injection, Solution
Product Images NDC 0078-0180
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sandostatin (NDC 0078-0180). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Octreotide Acetate Amino Acid Sequence (Sandostatin 02)
Principal Display Panelpackage Label – 50 Mcg/mlrx Only Ndc 0078 0180 01sandostatin Injection Octreotide Acetate50 Mcg/ml (0.05 mg/ml) (Sandostatin 03)
Principal Display Panelpackage Label – 100 Mcg/mlrx Only Ndc 0078 0181 01sandostatin Injectionoctreotide Acetate100 Mcg/ml (0.1 mg/ml) (Sandostatin 04)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.